If should be mentioned that, given the recent identification of a pervasive hypermutation activity targeting super-enhancer networks in DLBCL [109], it is expected that additional genes (or additional cases) will be found dysregulated in these tumours to sustain the aberrant activity of the NF-κB signaling cascade. Here, NFKB1 is linked to diffuse large B-cell lymphoma.